Breaking News, Financial News

Merck & Co.

SP integration continues, and a $1 billion reserve hedges another Vioxx settlement

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Merck 3Q10 3Q Revenues: $11.1 billion (-4%*) 3Q Earnings: $372 million (-89%) YTD Revenues: $33.9 billion (+1%*) YTD Earnings: $1.5 billion (-77%) Comments: Merck posted $9.6 billion in 3Q10 human health revenues, down from $10.1 billion of combined Merck and Schering-Plough sales in 3Q09. Merck put $950 million into reserve to settle an investigation by the Massachusetts district of the U.S. Attorney’s Office into Merck’s Vioxx marketing practices. In the quarter, Sin...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters